Brief: G1 Therapeutics’ COSELA (trilaciclib) Recommended in Updated Small Cell Lung Cancer Guidelines from the American Society of Clinical Oncology
18/10/2023 13:35
Oct 18 (Reuters) - G1 Therapeutics Inc GTHX.O :
* G1 THERAPEUTICS’ COSELA® (TRILACICLIB) RECOMMENDED IN
UPDATED
SMALL CELL LUNG CANCER GUIDELINES FROM THE AMERICAN SOCIETY OF
CLINICAL ONCOLOGY (ASCO)
Source text for Eikon: ID:nGNX2KcrCk
Further company coverage: GTHX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify